Aradigm
HomeAboutProductsTechnologiesInvestorsCareers
Press Releases

Investor Relations

Events & Presentations

Corporate Governance

Financial Information

Stock Information

Contact Us


All Releases
View Summary Aradigm Announces Second Quarter 2015 Financial Results
Aug 13, 2015
PDF 73.4 KB Add to Briefcase
View Summary Results from Pulmonary Non-Tuberculous Mycobacteria (PNTM) Study Using Aradigm's Liposomal Ciprofloxacin to be Presented at the American Thoracic Society 2015 International Conference
May 12, 2015
PDF 61.7 KB Add to Briefcase
View Summary Aradigm Announces First Quarter 2015 Financial Results
May 11, 2015
PDF 67.8 KB Add to Briefcase
View Summary Aradigm Announces Appointment of Dr. Robert A. Reed as Vice President, Regulatory (Chemistry, Manufacturing and Controls) and Quality
Apr 21, 2015
PDF 62.0 KB Add to Briefcase
View Summary Aradigm to Host Key Opinion Leader Breakfast and Webcast on April 23 in New York City
Apr 16, 2015
PDF 64.1 KB Add to Briefcase
View Summary Aradigm Announces Fourth Quarter 2014 and Full Year Financial Results
Mar 17, 2015
PDF 75.8 KB Add to Briefcase
View Summary Aradigm Corporation President & CEO Dr. Igor Gonda, Ph.D. to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios - 640 WGST AM's "Health Tech Talk Live"
Feb 27, 2015
PDF 18.3 KB Add to Briefcase
View Summary Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2015 on February 10
Feb 4, 2015
PDF 11.9 KB Add to Briefcase
View Summary Aradigm Granted Key Composition of Matter Patents for Pulmaquin in Europe and Australia
Jan 14, 2015
PDF 61.5 KB Add to Briefcase
View Summary Aradigm to Present at Biotech Showcase 2015 on January 14
Jan 8, 2015
PDF 11.8 KB Add to Briefcase
View Summary Aradigm to Present at the Stifel Healthcare Conference 2014
Nov 12, 2014
PDF 11.8 KB Add to Briefcase
View Summary Aradigm Announces Third Quarter 2014 Financial Results
Nov 7, 2014
PDF 22.8 KB Add to Briefcase
View Summary FDA Grants Fast Track Designation to Aradigm's Pulmaquin for Non-Cystic Fibrosis Bronchiectasis
Sep 4, 2014
PDF 62.8 KB Add to Briefcase
View Summary Aradigm Announces Second Quarter 2014 Financial Results
Aug 7, 2014
PDF 23.1 KB Add to Briefcase
View Summary Aradigm to Host Analyst Meeting and Webcast on August 12 in New York City
Aug 6, 2014
PDF 62.8 KB Add to Briefcase
View Summary Aradigm to Host Corporate Update Conference Call on June 26
Jun 25, 2014
PDF 12.1 KB Add to Briefcase
View Summary Aradigm Corporation Announces the Dosing of the First Patient in Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis (ORBIT-4)
Jun 23, 2014
PDF 62.2 KB Add to Briefcase
View Summary Aradigm Receives $5 Million Milestone For Dosing of the First Patient in Phase III Study of Pulmaquin in Non-Cystic Fibrosis Bronchiectasis
Jun 3, 2014
PDF 15.8 KB Add to Briefcase
View Summary FDA Grants QIDP Designation to Aradigm's Inhaled Antibiotic
May 20, 2014
PDF 16.7 KB Add to Briefcase
View Summary Aradigm Announces First Quarter 2014 Financial Results
May 14, 2014
PDF 20.0 KB Add to Briefcase
Showing 1-20 of 190 Page: 1 2 3 ... 10  Next 20
= add release to Briefcase
CONTACT NEWS & EVENTS LEGAL SITE MAP ©2015 Aradigm Corporation. All Rights Reserved.